Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources
  5. Charts

Charts

  • Diabetes (648)
  • Endocrinology (12)
  • Hyperglycemia (27)
  • Hypoglycemia (28)
  • Other (26)
  • Prediabetes (5)
  • Resources (221)
    • Charts (50)
    • Guidelines (61)
    • Letters (2)
    • Natural Medicines / Supplements (5)
    • Patient Education (15)
    • PL Voices (123)
    • Quality Measures (24)
  • Thyroid Disorders (49)
31 - 45 of 50 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Does My Patient with Diabetes Need an Aspirin, Statin, ACE Inhibitor, or ARB? November 2012
Guideline: Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy (2011) June 2011
Chart: Comparison of Common Meds for Diabetic Neuropathy June 2011
Commentary: New Drug: Byetta (Exenatide) May 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Other: See new Health Canada information concerning the restricted use of Avandia August 2010
Commentary: New Drug: Victoza (Liraglutide) July 2010
Other: Pancreatitis and Byetta (Exenatide) November 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Chart: Pharmacist Prescriptive Authority August 2009
Commentary: A Personalized Approach for A1c Goals March 2009
Chart: Insulin Glulisine (Apidra): New Rapid-Acting Insulin Analogue March 2009
Commentary: Insulin Use in Patients with Type 2 Diabetes February 2009
Commentary: How Much Insulin Is Too Much? January 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved